INS and psychiatric disorder: Insulin dysregulation plays a key role in cognitive decline in patients with AD (Cholerton et al., 2013; Kellar and Craft, 2020) and psychiatric disorders (Penninx and Lange, 2018) in such a way that peripheral insulin resistance decreases the ability of the hormone to cross the blood brain barrier (Schiöth et al., 2012).